Jorge Gomez-Gutierrez, PhD

University of Missouri – Columbia (MU)

The Gomez-Gutierrez Laboratory is primarily interested in microbial-based cancer therapy. We focus on investigating how virus- and bacteria-based therapies can be used to stop tumorigenesis and induce oncolysis and/or immune responses in cancers when conventional therapy is inadequate. Two microorganisms are being studied: the first is a conditionally replicating adenoviruses (CRAds) also known as oncolytic adenoviruses (OAd) which are cancer selective tumoricidal agents; the second is the probiotic lactic acid bacteria Lactococcus lactis (L. lactis), which is generally regarded as a safe (GRAS) organism and is used in dairy industry to make cheese and yogurt.